The Scientist

» cancer therapeutics

Most Recent

image: FDA Approves Bladder Cancer Immunotherapy

FDA Approves Bladder Cancer Immunotherapy

By | May 23, 2016

The US Food and Drug Administration greenlights Roche’s Tecentriq, which blocks a protein that obstructs the immune system’s ability to fight cancer.

0 Comments

image: FDA OKs Herpesvirus to Treat Cancer

FDA OKs Herpesvirus to Treat Cancer

By | October 28, 2015

The US Food and Drug Administration’s approval of an engineered herpesvirus for the treatment of melanoma marks the first oncolytic virus to enter the market.

0 Comments

image: CAR-T Therapies Get $1 Billion Boost

CAR-T Therapies Get $1 Billion Boost

By | July 1, 2015

The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.

0 Comments

image: The CAR T-Cell Race

The CAR T-Cell Race

By | April 1, 2015

Tumor-targeting T-cell therapies are generating remarkable remissions in hard-to-beat cancers—and attracting millions of dollars of investment along the way.

1 Comment

Scientists generate tumor-targeting molecules that can be used for imaging and treatment.

0 Comments

image: Tactical Maneuvers

Tactical Maneuvers

By | June 1, 2014

Scientists are creating viruses that naturally home in on tumor cells while simultaneously boosting the body’s immune system to fight cancer.

2 Comments

image: Targeting Tumors with Viruses

Targeting Tumors with Viruses

By | June 1, 2014

Stephanie Swift discusses the strategy of fighting cancer with viruses.

0 Comments

Popular Now

  1. Next Generation: Nanotube Scaffolds Reconnect Spinal Neurons
  2. Mapping the Human Connectome
    Daily News Mapping the Human Connectome

    A new map of human cortex combines data from multiple imaging modalities and comprises 180 distinct regions.

  3. Will Organs-in-a-Dish Ever Replace Animal Models?
  4. Your Office Has a Distinct Microbiome
RayBiotech